Abstract
PROSTAGLANDINS (PGs) have emerged as one of the principal mediators of the inflammatory process1–3. Elevation of tissue concentration of PGs was noted following inflammation3,4, or treatment with various hormones5,6, cyclic nucleotides (ref. 7 and U.Z., B. Strulovici and H.R.L., in preparation), serum8, drugs8,9 and antigen10. The beneficial effects of anti-inflammatory drugs have been correlated with their ability to suppress PG production either by curtailing precursor availability (glucocorticosteroids11,12) or by inhibiting PG synthetase activity (non-steroidal drugs1). Viral infections are associated with interferon production13 and with inflammation14. Little is known about the possible involvement of interferon in the inflammatory reaction, though it has been suggested that interferon may have anti-inflammatory properties15. It has been shown that an interferon inducer, double-stranded polyinosinate·polycytidylate [poly(I)·poly(C)], as well as human interferon, stimulate hyaluronic acid production by human synovial fibroblasts in culture16. Overproduction of hyaluronic acid is known to be associated with the inflammatory process16; the effect is prevented by cortisol or indomethacin16. We report here the stimulation by poly(I)·poly(C) and by human interferon of prostaglandin E (PGE) production by human synovial and foreskin fibroblasts in culture. Cortisol inhibited this effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vane, J. R. Nature new Biol. 231, 232–235 (1971).
Di Rosa, M., Giroud, J. P. & Willoughby, D. A. J. Pathol. 104, 15–29 (1971).
Floman, Y., Okon, E. & Zor, U. Clin. Orthop. Rel. Res. (in the press).
Ferreira, S. H., Moncada, S. & Vane, J. R. in Prostaglandin Synthetase Inhibitors (eds Robinson, H. J. & Vane, J. R.) 175–187 (Raven, New York, 1974).
Ramwell, P. W., Shaw, J. E., Douglas, W. W. & Poisner, A. M. Nature 210, 273–274 (1966).
Alexander, R. W. & Gimbrone, M. A. Jr, Proc. natn. Acad. Sci. U.S.A. 73, 1617–1620 (1976).
Hamprecht, B., Jaffe, B. M. & Philpott, G. W. FEBS Lett. 36, 193–198 (1973).
Hong, S-C. L., Polsky-Cynkin, R., & Levine, L. J. biol. Chem. 251, 776–780 (1976).
Robinson, D. R., Smith, H., McGuire, M. B. & Levine, L. Prostaglandins 10, 67–85 (1975).
Webb, D. R. & Osheroff, P. L. Proc. natn. Acad. Sci. U.S.A. 73, 1300–1304 (1976).
Gryglewski, R. J., Panczenko, B., Korbut, R., Grodzinska, L. & Ocetkiewicz, A. Prostaglandins 10, 343–356 (1975).
Floman, Y. & Zor, U. Prostaglandins 12, 403–413 (1976).
Isaacs, A. & Lindermann, J. Proc. R. Soc. B 147, 258–267 (1957).
Smith, J. W. & Sanford, J. P. Ann. Intern. Med. 67, 651–659 (1967).
Koltai, M. & Mécs, E. Nature 242, 525–526 (1973).
Yaron, M., Yaron, I., Smetana, O., Eylan, E. & Herzberg, M. Arthritis Rheumatism 19, 1315–1320 (1976).
Castor, C. W., Prince, R. K. & Dorstewitz, E. L. Lab. Invest. 11, 703–713 (1962).
Havell, E. A. & Vilcek, J. Antimicrob. Agents Chemother 2, 476–484 (1972).
Anfinsen, C. B., Bose, S., Corley, L. & Gurari-Rotman, D. Proc. natn. Acad. Sci. U.S.A. 71, 3139–3142 (1974). Gurari
Bauminger, S., Zor, U. & Lindner, H. R. Prostaglandins 4, 313–324 (1973).
Kantrowitz, F., Robinson, D. R., McGuire, M. B. & Levine, L. Nature 258, 737–739 (1975).
Collier, H. O. J. Nature 232, 17–19 (1971).
Kilbourne, E. D. & Horsfall, F. L., Jr, Proc. Soc. exp. biol. Med. 77, 135–138 (1951).
Stanley, E. D., Jackson, G. G., Panusarn, C., Rubenis, M. & Dirda, V. J. Am. Med. Assoc. 231, 1248–1251 (1975).
Weinstein, Y., Brodeur, B. R., Melmon, K. L. & Merigan, T. C. Immunology (in the press).
Santoro, M. G., Philpott, G. W. & Jaffe, B. M. Nature 263, 777–779 (1976).
Johnson, G. S. & Pastan, I. J. natn. Cancer Inst. 47, 1357–1364 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
YARON, M., YARON, I., GURARI-ROTMAN, D. et al. Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I) · poly(C) and human interferon. Nature 267, 457–459 (1977). https://doi.org/10.1038/267457a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/267457a0
This article is cited by
-
Interferon treatment of human malignancies - a short review
Medical Oncology and Tumor Pharmacotherapy (1993)
-
Arachidonic acid regulates the binding of human interferon in human skin fibroblasts
Lipids (1990)
-
Serum interferon activity in inflammatory bowel disease
Inflammation (1988)
-
Interferon-β can induce the production of plasminogen activator by cultured human cancer cells
Experientia (1987)
-
Regulation of cell growth by interferon
Cancer and Metastasis Review (1987)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.